What is AbbVie's stock-based comp?

AbbVie (ABBV) reported stock-based comp of $444M in Q1 2026.

How has AbbVie's stock-based comp changed year-over-year?

AbbVie's stock-based comp increased by 8.3% year-over-year, from $410M to $444M.

What is the long-term trend for AbbVie's stock-based comp?

Over 4 years (2021 to 2025), AbbVie's stock-based comp has grown at a 8.4% compound annual growth rate (CAGR), from $692M to $955M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

AbbVie ABBV Stock-Based Comp

Stock-Based Comp at other companies

Eli LillyLLY

$161M+4.5%

PfizerPFE

$272M+60.0%

Johnson & JohnsonJNJ

$300M+4.2%

AmgenAMGN

$75M-11.8%

Cardinal HealthCAH

$129M+316%

Vertex PharmaceuticalsVRTX

$166.4M+0.2%

Other financials

Income statement

See full

Revenue$15.0B+12.4%

Gross profit$10.8B+15.4%

Operating income$4.0B+6.9%

Net income$695.0M-46.0%

EPS (diluted)$0.39-45.8%

Balance sheet

See full

Cash & equivalents$9.4B+81.5%

Total debt$62.4B+1.8%

Total equity-$6.7B-569%

Total assets$136.46B+0.2%

Cash flow

See full

Operating cash flow$3.8B+134%

CapEx$265.0M+12.8%

Free cash flow$3.6B+155%

Valuation

See full

Market cap$447.62B+36.6%

P/E123.1×+36.0×

P/S7.1×+1.5×

Profitability

See full

Gross margin70.7%0.0pp

Operating margin24.4%—

Net margin5.8%-1.5pp

FCF margin31.8%+5.0pp

Returns & leverage

See full

Return on equity89%+32.7pp

Debt / equity46.6×+38.6×

Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbbVie's stock-based comp?: AbbVie (ABBV) reported stock-based comp of $444M in Q1 2026.
How has AbbVie's stock-based comp changed year-over-year?: AbbVie's stock-based comp increased by 8.3% year-over-year, from $410M to $444M.
What is the long-term trend for AbbVie's stock-based comp?: Over 4 years (2021 to 2025), AbbVie's stock-based comp has grown at a 8.4% compound annual growth rate (CAGR), from $692M to $955M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.